Doxorubicin/ifosfamide/mesnaLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2039卷 / 1期

关键词：

D O I：

10.1007/s40278-024-72627-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：190 / 190

相关论文

共 50 条

[31] Gemcitabine/ifosfamide/pirarubicinLack of efficacy: case report
Reactions Weekly, 2023, 1950 (1) : 203 - 203
[32] Cisplatin/ifosfamide/paclitaxelLack of efficacy: case report
Reactions Weekly, 2023, 1964 (1) : 136 - 136
[33] Etoposide/ifosfamide/vincristineLack of efficacy: case report
Reactions Weekly, 2021, 1847 (1) : 199 - 199
[34] Dactinomycin/ifosfamide/vincristineLack of efficacy: case report
Reactions Weekly, 2022, 1896 (1) : 166 - 166
[35] Cisplatin/ifosfamide/paclitaxelLack of efficacy: case report
Reactions Weekly, 2023, 1965 (1) : 158 - 158
[36] Antineoplastics/mesnaLack of efficacy
Reactions Weekly, 2024, 2012 (1) : 47 - 47
[37] Doxorubicin/ifosfamideLack of efficacy: case report
Reactions Weekly, 2023, 1967 (1) : 151 - 151
[38] Doxorubicin/ifosfamideLack of efficacy: case report
Reactions Weekly, 2021, 1847 (1) : 185 - 185
[39] Doxorubicin/ifosfamideLack of efficacy: case report
Reactions Weekly, 2022, 1908 (1) : 228 - 228
[40] Doxorubicin/olaratumabLack of efficacy: case report
Reactions Weekly, 2022, 1893 (1) : 128 - 128

← 1 2 3 4 5 →